137 related articles for article (PubMed ID: 37559099)
1. Baseline demographic, clinical and multimodal imaging features of young patients with type 2 macular telangiectasia.
Reddy NG; Prabhu V; Sharma SV; Acharya I; Mangla R; Yadav NK; Chhablani J; Narayanan R; Venkatesh R
Int J Retina Vitreous; 2023 Aug; 9(1):47. PubMed ID: 37559099
[TBL] [Abstract][Full Text] [Related]
2. Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity.
Venkatesh R; Reddy NG; Mishra P; Agrawal S; Mutalik D; Yadav NK; Chhablani J
Int J Retina Vitreous; 2022 Apr; 8(1):26. PubMed ID: 35382904
[TBL] [Abstract][Full Text] [Related]
3. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging.
Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S
Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211
[TBL] [Abstract][Full Text] [Related]
5. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of retinal pigment clumps in Type 2 macular telangiectasia (MacTel).
Venkatesh R; Agrawal S; Reddy NG; Mishra P; Mutalik D; Yadav NK; Chhablani J
Eye (Lond); 2023 Apr; 37(6):1061-1066. PubMed ID: 35422496
[TBL] [Abstract][Full Text] [Related]
7. The preproliferative stage in type 2 macular telangiectasia (MacTel type 2).
Venkatesh R; Reddy NG; Mishra P; Pereira A; Mutalik D; Agrawal S; Bhatt A; Yadav NK; Chhablani J
Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):121-132. PubMed ID: 34410484
[TBL] [Abstract][Full Text] [Related]
8. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen retinopathy and macular telangiectasia: A comparative case series.
Venkatesh R; Sharief S; Jayadev C; Reddy NG; Mangla R; Agrawal R; Yadav NK; Chhablani J
Eur J Ophthalmol; 2022 Nov; ():11206721221142637. PubMed ID: 36437624
[TBL] [Abstract][Full Text] [Related]
10. Type-3 macular neovascularization in a case of long-standing macular telangiectasia type-2.
Chandran K; Desai S; Giridhar A
Oman J Ophthalmol; 2023; 16(2):377-381. PubMed ID: 37602186
[TBL] [Abstract][Full Text] [Related]
11. Vitreomacular interface abnormalities in type 2 macular telangiectasia (MacTel).
Venkatesh R; Mangla R; Handa A; Chitturi SP; Parmar Y; Sangoram R; Yadav NK; Chhablani J
Graefes Arch Clin Exp Ophthalmol; 2024 May; 262(5):1455-1463. PubMed ID: 38108907
[TBL] [Abstract][Full Text] [Related]
12. CHARACTERIZING RETINAL-CHOROIDAL ANASTOMOSIS IN MACULAR TELANGIECTASIA TYPE 2 WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Breazzano MP; Yannuzzi LA; Spaide RF
Retina; 2020 Jan; 40(1):92-98. PubMed ID: 31246676
[TBL] [Abstract][Full Text] [Related]
13. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
14. Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?
Kelkar AS; Kelkar JA; Tidke S; Agarwal A; Bolisetty M; Kelkar S
Indian J Ophthalmol; 2021 Dec; 69(12):3570-3576. PubMed ID: 34826997
[TBL] [Abstract][Full Text] [Related]
15. Relevance of Multicolor Imaging in Type 2 Macular Telangiectasia.
Venkatesh R; Pereira A; Bavaharan B; Jain K; Aseem A; Sangai S; Yadav NK
J Curr Ophthalmol; 2020; 32(4):375-380. PubMed ID: 33553840
[TBL] [Abstract][Full Text] [Related]
16. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
Solberg Y; Dysli C; Wolf S; Zinkernagel MS
Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
[TBL] [Abstract][Full Text] [Related]
17. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.
Baumüller S; Charbel Issa P; Scholl HP; Schmitz-Valckenberg S; Holz FG
Ophthalmology; 2010 Nov; 117(11):2162-8. PubMed ID: 20557944
[TBL] [Abstract][Full Text] [Related]
18. Demographic features of idiopathic macular telangiectasia in Japanese patients.
Maruko I; Iida T; Sugano Y; Ojima A; Oyamada H; Sekiryu T
Jpn J Ophthalmol; 2012 Mar; 56(2):152-8. PubMed ID: 22219035
[TBL] [Abstract][Full Text] [Related]
19. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.
Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P
Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659
[TBL] [Abstract][Full Text] [Related]
20. Functional relevance of macular telangiectasia (MacTel) area on multicolour imaging in type 2 MacTel.
Venkatesh R; Reddy NG; Agrawal S; Pereira A; Mutalik D; Mishra P; Yadav NK; Chhablani J
Eur J Ophthalmol; 2022 Jul; 32(4):2368-2374. PubMed ID: 34488467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
